GB0009591D0 - Medical combinations - Google Patents
Medical combinationsInfo
- Publication number
- GB0009591D0 GB0009591D0 GBGB0009591.9A GB0009591A GB0009591D0 GB 0009591 D0 GB0009591 D0 GB 0009591D0 GB 0009591 A GB0009591 A GB 0009591A GB 0009591 D0 GB0009591 D0 GB 0009591D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- medical combinations
- medical
- combinations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0009591.9A GB0009591D0 (en) | 2000-04-18 | 2000-04-18 | Medical combinations |
AU46723/01A AU4672301A (en) | 2000-04-18 | 2001-04-11 | Medical combinations comprising formoterol and fluticasone proprionate |
PCT/GB2001/001649 WO2001078745A1 (en) | 2000-04-18 | 2001-04-11 | Medical combinations comprising formoterol and fluticasone proprionate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0009591.9A GB0009591D0 (en) | 2000-04-18 | 2000-04-18 | Medical combinations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0009591D0 true GB0009591D0 (en) | 2000-06-07 |
Family
ID=9890176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0009591.9A Ceased GB0009591D0 (en) | 2000-04-18 | 2000-04-18 | Medical combinations |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4672301A (en) |
GB (1) | GB0009591D0 (en) |
WO (1) | WO2001078745A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0012260D0 (en) | 2000-05-19 | 2000-07-12 | Astrazeneca Ab | Novel composition |
US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
US20020132803A1 (en) * | 2001-01-05 | 2002-09-19 | Mahendra Dedhiya | Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus |
GB0106031D0 (en) * | 2001-03-12 | 2001-05-02 | Glaxo Group Ltd | Use |
UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
DE10130371A1 (en) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | New drug compositions based on anticholinergics, corticosteroids and betamimetics |
US7931022B2 (en) | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
US7084153B2 (en) | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
DE10216429A1 (en) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Synergistic medicaments for treating inflammatory or obstructive respiratory tract diseases, containing quaternized scopine ester anticholinergic agent and steroid, e.g. budesonide |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
EP2319584A1 (en) * | 2002-08-29 | 2011-05-11 | Cipla Ltd. | Pharmaceutical products and compositions comprising salmeterol, ciclesonide and tiotropium |
SE527191C2 (en) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhaler device and combined doses of tiotropium and fluticasone |
SE527069C2 (en) | 2003-06-19 | 2005-12-13 | Mederio Ag | Method and apparatus for administering drug powder |
DE10347994A1 (en) | 2003-10-15 | 2005-06-16 | Pari GmbH Spezialisten für effektive Inhalation | Aqueous aerosol preparation |
DE602005026225D1 (en) | 2004-03-12 | 2011-03-24 | Cipla Ltd | Sterilization process for steroids |
EP1712220A1 (en) * | 2005-04-15 | 2006-10-18 | PARI GmbH Spezialisten für effektive Inhalation | Pharmaceutical aerosol composition |
US8834931B2 (en) | 2009-12-25 | 2014-09-16 | Mahmut Bilgic | Dry powder formulation containing tiotropium for inhalation |
TR201000622A2 (en) * | 2010-01-28 | 2011-08-22 | Bi̇lgi̇ç Mahmut | Pharmaceutical combinations containing tiotropium. |
WO2011093811A2 (en) * | 2010-01-29 | 2011-08-04 | Mahmut Bilgic | Pharmaceutical preparations comprising formoterol and fluticasone |
WO2012049444A1 (en) | 2010-10-12 | 2012-04-19 | Cipla Limited | Pharmaceutical composition |
KR20150002774A (en) | 2012-04-11 | 2015-01-07 | 시플라 리미티드 | Pharmaceutical composition comprising arformoterol and fluticasone furoate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY1291A (en) * | 1980-02-15 | 1985-10-18 | Glaxo Group Ltd | Androstane 17 beta carbothioates |
US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
DK0938467T3 (en) * | 1996-11-11 | 2002-10-07 | Sepracor Inc | Process for preparing optically pure isomers of formoterol |
GB9903759D0 (en) * | 1999-02-18 | 1999-04-14 | Novartis Ag | Organic compounds |
-
2000
- 2000-04-18 GB GBGB0009591.9A patent/GB0009591D0/en not_active Ceased
-
2001
- 2001-04-11 WO PCT/GB2001/001649 patent/WO2001078745A1/en active Application Filing
- 2001-04-11 AU AU46723/01A patent/AU4672301A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU4672301A (en) | 2001-10-30 |
WO2001078745A1 (en) | 2001-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0302360A3 (en) | Medical arrangement | |
GB0009591D0 (en) | Medical combinations | |
EP1296699A4 (en) | Therapeutic agents - iii | |
GB0009606D0 (en) | Therapeutic combinations | |
GB0011244D0 (en) | Tissue regrafting | |
AU8420301A (en) | Use | |
EP1264611A4 (en) | Syringe | |
GB0025788D0 (en) | Use | |
GB0030541D0 (en) | Medical uses | |
GB0005070D0 (en) | Use | |
GB0031321D0 (en) | Treatment | |
GB0029634D0 (en) | Use | |
GB0016690D0 (en) | Eplthelial diagnostic aid | |
GB2358857B (en) | Coffins | |
GB0026771D0 (en) | Medical uses | |
GB0015251D0 (en) | Medical unit | |
AU143950S (en) | Tissue | |
AU143726S (en) | Tissue | |
AU143951S (en) | Tissue | |
AU144071S (en) | Tissue | |
AU9481201A (en) | Human nedd-1 | |
HU1901U (en) | Hearse | |
GB0017076D0 (en) | Medicament | |
GB0017092D0 (en) | Medicament | |
GB0017727D0 (en) | Catheter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |